nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—SLCO1A2—Quinine—malaria	0.0643	0.0941	CbGbCtD
Naproxen—SLC22A6—Doxycycline—malaria	0.0574	0.084	CbGbCtD
Naproxen—SLCO1A2—Quinidine—malaria	0.0565	0.0827	CbGbCtD
Naproxen—CYP2C8—Sulfadiazine—malaria	0.0498	0.0729	CbGbCtD
Naproxen—CYP2C8—Pyrimethamine—malaria	0.0498	0.0729	CbGbCtD
Naproxen—PTGS2—Dapsone—malaria	0.0399	0.0584	CbGbCtD
Naproxen—CYP2C9—Pyrimethamine—malaria	0.0348	0.0509	CbGbCtD
Naproxen—CYP2C9—Sulfadiazine—malaria	0.0348	0.0509	CbGbCtD
Naproxen—PTGS1—Dapsone—malaria	0.0337	0.0493	CbGbCtD
Naproxen—CYP1A2—Proguanil—malaria	0.0308	0.0451	CbGbCtD
Naproxen—CYP2C9—Artemether—malaria	0.0296	0.0432	CbGbCtD
Naproxen—CYP2C9—Proguanil—malaria	0.0278	0.0407	CbGbCtD
Naproxen—CYP2C8—Quinine—malaria	0.0257	0.0376	CbGbCtD
Naproxen—CYP2C8—Quinidine—malaria	0.0226	0.033	CbGbCtD
Naproxen—CYP1A2—Pentoxifylline—malaria	0.0222	0.0324	CbGbCtD
Naproxen—CYP1A2—Quinine—malaria	0.0199	0.0291	CbGbCtD
Naproxen—CYP2C8—Dapsone—malaria	0.0195	0.0285	CbGbCtD
Naproxen—CYP2C9—Quinine—malaria	0.0179	0.0262	CbGbCtD
Naproxen—CYP1A2—Quinidine—malaria	0.0175	0.0256	CbGbCtD
Naproxen—CYP2C9—Quinidine—malaria	0.0157	0.023	CbGbCtD
Naproxen—CYP2C9—Dapsone—malaria	0.0136	0.0199	CbGbCtD
Naproxen—UGT1A1—blood plasma—malaria	0.00368	0.0689	CbGeAlD
Naproxen—UGT1A1—hematopoietic system—malaria	0.00203	0.0381	CbGeAlD
Naproxen—UGT2B7—kidney—malaria	0.00196	0.0367	CbGeAlD
Naproxen—CYP2C8—blood plasma—malaria	0.00174	0.0326	CbGeAlD
Naproxen—UGT1A1—kidney—malaria	0.00167	0.0312	CbGeAlD
Naproxen—UGT2B7—digestive system—malaria	0.00166	0.0312	CbGeAlD
Naproxen—CYP1A2—blood plasma—malaria	0.00163	0.0305	CbGeAlD
Naproxen—PTGS1—endothelium—malaria	0.00159	0.0298	CbGeAlD
Naproxen—CYP2C9—blood plasma—malaria	0.00154	0.029	CbGeAlD
Naproxen—PTGS2—endothelium—malaria	0.00152	0.0285	CbGeAlD
Naproxen—AKR1C3—blood—malaria	0.00146	0.0274	CbGeAlD
Naproxen—UGT1A1—digestive system—malaria	0.00141	0.0265	CbGeAlD
Naproxen—AKR1C3—bone marrow—malaria	0.00141	0.0265	CbGeAlD
Naproxen—PTGS1—blood plasma—malaria	0.00141	0.0264	CbGeAlD
Naproxen—SLCO1A2—hematopoietic system—malaria	0.00138	0.0258	CbGeAlD
Naproxen—PTGS2—blood plasma—malaria	0.00135	0.0253	CbGeAlD
Naproxen—UGT1A1—blood—malaria	0.00135	0.0253	CbGeAlD
Naproxen—UGT2B7—liver—malaria	0.00124	0.0232	CbGeAlD
Naproxen—AKR1C3—liver—malaria	0.00114	0.0214	CbGeAlD
Naproxen—SLCO1A2—kidney—malaria	0.00113	0.0212	CbGeAlD
Naproxen—UGT1A1—liver—malaria	0.00105	0.0197	CbGeAlD
Naproxen—CYP2C8—hematopoietic system—malaria	0.000962	0.018	CbGeAlD
Naproxen—SLCO1A2—digestive system—malaria	0.000957	0.0179	CbGeAlD
Naproxen—AKR1C3—brain—malaria	0.000906	0.017	CbGeAlD
Naproxen—SLC22A6—brain—malaria	0.000902	0.0169	CbGeAlD
Naproxen—CYP1A2—hematopoietic system—malaria	0.0009	0.0169	CbGeAlD
Naproxen—CYP2C9—hematopoietic system—malaria	0.000854	0.016	CbGeAlD
Naproxen—CYP2C8—kidney—malaria	0.000788	0.0148	CbGeAlD
Naproxen—PTGS1—hematopoietic system—malaria	0.00078	0.0146	CbGeAlD
Naproxen—PTGS2—hematopoietic system—malaria	0.000745	0.014	CbGeAlD
Naproxen—SLCO1A2—liver—malaria	0.000713	0.0134	CbGeAlD
Naproxen—ALB—liver—malaria	0.000709	0.0133	CbGeAlD
Naproxen—PTGS1—kidney—malaria	0.000639	0.012	CbGeAlD
Naproxen—CYP2C8—blood—malaria	0.000637	0.0119	CbGeAlD
Naproxen—CYP1A2—digestive system—malaria	0.000626	0.0117	CbGeAlD
Naproxen—PTGS2—kidney—malaria	0.000611	0.0115	CbGeAlD
Naproxen—CYP1A2—blood—malaria	0.000596	0.0112	CbGeAlD
Naproxen—CYP2C9—digestive system—malaria	0.000594	0.0111	CbGeAlD
Naproxen—CYP2C9—blood—malaria	0.000566	0.0106	CbGeAlD
Naproxen—SLCO1A2—brain—malaria	0.000566	0.0106	CbGeAlD
Naproxen—ALB—brain—malaria	0.000562	0.0105	CbGeAlD
Naproxen—PTGS1—digestive system—malaria	0.000542	0.0102	CbGeAlD
Naproxen—PTGS2—digestive system—malaria	0.000518	0.00972	CbGeAlD
Naproxen—PTGS1—blood—malaria	0.000517	0.00969	CbGeAlD
Naproxen—CYP2C8—liver—malaria	0.000498	0.00934	CbGeAlD
Naproxen—PTGS2—blood—malaria	0.000494	0.00926	CbGeAlD
Naproxen—PTGS2—bone marrow—malaria	0.000478	0.00896	CbGeAlD
Naproxen—CYP1A2—liver—malaria	0.000466	0.00874	CbGeAlD
Naproxen—CYP2C9—liver—malaria	0.000443	0.0083	CbGeAlD
Naproxen—CYP2C8—brain—malaria	0.000395	0.00741	CbGeAlD
Naproxen—PTGS2—liver—malaria	0.000386	0.00724	CbGeAlD
Naproxen—PTGS1—brain—malaria	0.000321	0.00601	CbGeAlD
Naproxen—PTGS2—brain—malaria	0.000306	0.00575	CbGeAlD
Naproxen—Vision blurred—Dapsone—malaria	0.000216	0.000928	CcSEcCtD
Naproxen—Erythema multiforme—Quinidine barbiturate—malaria	0.000214	0.000916	CcSEcCtD
Naproxen—Muscle spasms—Clindamycin—malaria	0.000214	0.000916	CcSEcCtD
Naproxen—Decreased appetite—Sulfadiazine—malaria	0.000212	0.000908	CcSEcCtD
Naproxen—Eye disorder—Quinidine barbiturate—malaria	0.000211	0.000906	CcSEcCtD
Naproxen—Tinnitus—Quinidine barbiturate—malaria	0.000211	0.000904	CcSEcCtD
Naproxen—Gastrointestinal disorder—Sulfadiazine—malaria	0.00021	0.000902	CcSEcCtD
Naproxen—Cardiac disorder—Quinidine barbiturate—malaria	0.00021	0.000899	CcSEcCtD
Naproxen—Vertigo—Dapsone—malaria	0.000206	0.000885	CcSEcCtD
Naproxen—Vision blurred—Quinine—malaria	0.000205	0.000881	CcSEcCtD
Naproxen—Vision blurred—Quinidine—malaria	0.000205	0.000881	CcSEcCtD
Naproxen—Anaemia—Clindamycin—malaria	0.000205	0.000881	CcSEcCtD
Naproxen—Tremor—Quinine—malaria	0.000204	0.000876	CcSEcCtD
Naproxen—Tremor—Quinidine—malaria	0.000204	0.000876	CcSEcCtD
Naproxen—Immune system disorder—Quinidine barbiturate—malaria	0.000204	0.000875	CcSEcCtD
Naproxen—ALB—Lipid and lipoprotein metabolism—SCARB1—malaria	0.000204	0.00679	CbGpPWpGaD
Naproxen—Immune system disorder—Pentoxifylline—malaria	0.000204	0.000874	CcSEcCtD
Naproxen—Mediastinal disorder—Quinidine barbiturate—malaria	0.000204	0.000873	CcSEcCtD
Naproxen—Chills—Quinidine barbiturate—malaria	0.000203	0.00087	CcSEcCtD
Naproxen—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000202	0.00672	CbGpPWpGaD
Naproxen—Arrhythmia—Pentoxifylline—malaria	0.000202	0.000864	CcSEcCtD
Naproxen—ALB—Vitamin B12 Metabolism—SCARB1—malaria	0.000201	0.00668	CbGpPWpGaD
Naproxen—Cough—Dapsone—malaria	0.0002	0.00086	CcSEcCtD
Naproxen—Vertigo—Clindamycin—malaria	0.0002	0.000856	CcSEcCtD
Naproxen—Angioedema—Quinidine—malaria	0.000199	0.000854	CcSEcCtD
Naproxen—Angioedema—Quinine—malaria	0.000199	0.000854	CcSEcCtD
Naproxen—Gastrointestinal pain—Sulfadiazine—malaria	0.000199	0.000854	CcSEcCtD
Naproxen—Leukopenia—Clindamycin—malaria	0.000199	0.000853	CcSEcCtD
Naproxen—Mental disorder—Quinidine barbiturate—malaria	0.000198	0.000849	CcSEcCtD
Naproxen—Malnutrition—Quinidine barbiturate—malaria	0.000197	0.000844	CcSEcCtD
Naproxen—Erythema—Quinidine barbiturate—malaria	0.000197	0.000844	CcSEcCtD
Naproxen—Erythema—Pentoxifylline—malaria	0.000196	0.000842	CcSEcCtD
Naproxen—Vertigo—Quinidine—malaria	0.000196	0.00084	CcSEcCtD
Naproxen—Vertigo—Quinine—malaria	0.000196	0.00084	CcSEcCtD
Naproxen—Syncope—Quinidine—malaria	0.000195	0.000838	CcSEcCtD
Naproxen—Syncope—Quinine—malaria	0.000195	0.000838	CcSEcCtD
Naproxen—Leukopenia—Quinidine—malaria	0.000195	0.000837	CcSEcCtD
Naproxen—Leukopenia—Quinine—malaria	0.000195	0.000837	CcSEcCtD
Naproxen—UGT2B7—Biological oxidations—HPGDS—malaria	0.000194	0.00647	CbGpPWpGaD
Naproxen—Flatulence—Pentoxifylline—malaria	0.000193	0.00083	CcSEcCtD
Naproxen—Urticaria—Sulfadiazine—malaria	0.000193	0.00083	CcSEcCtD
Naproxen—Tension—Quinidine barbiturate—malaria	0.000193	0.000828	CcSEcCtD
Naproxen—Tension—Pentoxifylline—malaria	0.000193	0.000826	CcSEcCtD
Naproxen—Palpitations—Quinidine—malaria	0.000193	0.000826	CcSEcCtD
Naproxen—Palpitations—Quinine—malaria	0.000193	0.000826	CcSEcCtD
Naproxen—Body temperature increased—Sulfadiazine—malaria	0.000192	0.000826	CcSEcCtD
Naproxen—Abdominal pain—Sulfadiazine—malaria	0.000192	0.000826	CcSEcCtD
Naproxen—Hypertension—Clindamycin—malaria	0.000192	0.000823	CcSEcCtD
Naproxen—Loss of consciousness—Quinidine—malaria	0.000192	0.000822	CcSEcCtD
Naproxen—Loss of consciousness—Quinine—malaria	0.000192	0.000822	CcSEcCtD
Naproxen—Nervousness—Quinidine barbiturate—malaria	0.000191	0.000819	CcSEcCtD
Naproxen—Nervousness—Pentoxifylline—malaria	0.000191	0.000818	CcSEcCtD
Naproxen—Convulsion—Quinidine—malaria	0.000189	0.00081	CcSEcCtD
Naproxen—Convulsion—Quinine—malaria	0.000189	0.00081	CcSEcCtD
Naproxen—Muscle spasms—Pentoxifylline—malaria	0.000189	0.00081	CcSEcCtD
Naproxen—Discomfort—Clindamycin—malaria	0.000187	0.000802	CcSEcCtD
Naproxen—Chest pain—Quinine—malaria	0.000186	0.000796	CcSEcCtD
Naproxen—Myalgia—Quinine—malaria	0.000186	0.000796	CcSEcCtD
Naproxen—Myalgia—Quinidine—malaria	0.000186	0.000796	CcSEcCtD
Naproxen—Chest pain—Quinidine—malaria	0.000186	0.000796	CcSEcCtD
Naproxen—Vision blurred—Quinidine barbiturate—malaria	0.000185	0.000795	CcSEcCtD
Naproxen—Vision blurred—Pentoxifylline—malaria	0.000185	0.000794	CcSEcCtD
Naproxen—Tremor—Quinidine barbiturate—malaria	0.000184	0.00079	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000184	0.00079	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000184	0.00079	CcSEcCtD
Naproxen—Tremor—Pentoxifylline—malaria	0.000184	0.000789	CcSEcCtD
Naproxen—Tachycardia—Dapsone—malaria	0.000183	0.000785	CcSEcCtD
Naproxen—Ill-defined disorder—Pentoxifylline—malaria	0.000182	0.000781	CcSEcCtD
Naproxen—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000182	0.00605	CbGpPWpGaD
Naproxen—Anaemia—Pentoxifylline—malaria	0.000181	0.000778	CcSEcCtD
Naproxen—Anaphylactic shock—Clindamycin—malaria	0.000181	0.000778	CcSEcCtD
Naproxen—Angioedema—Quinidine barbiturate—malaria	0.00018	0.000771	CcSEcCtD
Naproxen—Angioedema—Pentoxifylline—malaria	0.000179	0.00077	CcSEcCtD
Naproxen—Hypersensitivity—Sulfadiazine—malaria	0.000179	0.000769	CcSEcCtD
Naproxen—Confusional state—Quinidine—malaria	0.000179	0.000769	CcSEcCtD
Naproxen—Confusional state—Quinine—malaria	0.000179	0.000769	CcSEcCtD
Naproxen—Oedema—Quinine—malaria	0.000178	0.000763	CcSEcCtD
Naproxen—Oedema—Quinidine—malaria	0.000178	0.000763	CcSEcCtD
Naproxen—Thrombocytopenia—Clindamycin—malaria	0.000178	0.000761	CcSEcCtD
Naproxen—Malaise—Pentoxifylline—malaria	0.000177	0.000759	CcSEcCtD
Naproxen—Vertigo—Quinidine barbiturate—malaria	0.000177	0.000758	CcSEcCtD
Naproxen—Syncope—Quinidine barbiturate—malaria	0.000176	0.000757	CcSEcCtD
Naproxen—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000176	0.00587	CbGpPWpGaD
Naproxen—Leukopenia—Quinidine barbiturate—malaria	0.000176	0.000755	CcSEcCtD
Naproxen—Leukopenia—Pentoxifylline—malaria	0.000176	0.000754	CcSEcCtD
Naproxen—Shock—Quinidine—malaria	0.000175	0.000751	CcSEcCtD
Naproxen—Shock—Quinine—malaria	0.000175	0.000751	CcSEcCtD
Naproxen—Nervous system disorder—Quinidine—malaria	0.000174	0.000748	CcSEcCtD
Naproxen—Nervous system disorder—Quinine—malaria	0.000174	0.000748	CcSEcCtD
Naproxen—Thrombocytopenia—Quinidine—malaria	0.000174	0.000747	CcSEcCtD
Naproxen—Thrombocytopenia—Quinine—malaria	0.000174	0.000747	CcSEcCtD
Naproxen—Palpitations—Quinidine barbiturate—malaria	0.000174	0.000746	CcSEcCtD
Naproxen—Tachycardia—Quinidine—malaria	0.000174	0.000745	CcSEcCtD
Naproxen—Tachycardia—Quinine—malaria	0.000174	0.000745	CcSEcCtD
Naproxen—Palpitations—Pentoxifylline—malaria	0.000174	0.000744	CcSEcCtD
Naproxen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000173	0.00576	CbGpPWpGaD
Naproxen—Loss of consciousness—Quinidine barbiturate—malaria	0.000173	0.000742	CcSEcCtD
Naproxen—Skin disorder—Quinine—malaria	0.000173	0.000741	CcSEcCtD
Naproxen—Skin disorder—Quinidine—malaria	0.000173	0.000741	CcSEcCtD
Naproxen—Pruritus—Sulfadiazine—malaria	0.000172	0.000739	CcSEcCtD
Naproxen—Hyperhidrosis—Quinine—malaria	0.000172	0.000738	CcSEcCtD
Naproxen—Hyperhidrosis—Quinidine—malaria	0.000172	0.000738	CcSEcCtD
Naproxen—Convulsion—Quinidine barbiturate—malaria	0.00017	0.000731	CcSEcCtD
Naproxen—Convulsion—Pentoxifylline—malaria	0.00017	0.00073	CcSEcCtD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.00017	0.00565	CbGpPWpGaD
Naproxen—Anorexia—Quinidine—malaria	0.00017	0.000727	CcSEcCtD
Naproxen—Anorexia—Quinine—malaria	0.00017	0.000727	CcSEcCtD
Naproxen—Insomnia—Dapsone—malaria	0.00017	0.000727	CcSEcCtD
Naproxen—Hypertension—Pentoxifylline—malaria	0.00017	0.000727	CcSEcCtD
Naproxen—Hypotension—Clindamycin—malaria	0.000169	0.000727	CcSEcCtD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000169	0.00563	CbGpPWpGaD
Naproxen—Chest pain—Quinidine barbiturate—malaria	0.000167	0.000718	CcSEcCtD
Naproxen—Arthralgia—Quinidine barbiturate—malaria	0.000167	0.000718	CcSEcCtD
Naproxen—Myalgia—Quinidine barbiturate—malaria	0.000167	0.000718	CcSEcCtD
Naproxen—Myalgia—Pentoxifylline—malaria	0.000167	0.000717	CcSEcCtD
Naproxen—Chest pain—Pentoxifylline—malaria	0.000167	0.000717	CcSEcCtD
Naproxen—Anxiety—Quinidine barbiturate—malaria	0.000167	0.000716	CcSEcCtD
Naproxen—Diarrhoea—Sulfadiazine—malaria	0.000167	0.000715	CcSEcCtD
Naproxen—Anxiety—Pentoxifylline—malaria	0.000167	0.000714	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000166	0.000713	CcSEcCtD
Naproxen—Hypotension—Quinine—malaria	0.000166	0.000713	CcSEcCtD
Naproxen—Hypotension—Quinidine—malaria	0.000166	0.000713	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000166	0.00553	CbGpPWpGaD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000166	0.000712	CcSEcCtD
Naproxen—Discomfort—Pentoxifylline—malaria	0.000165	0.000708	CcSEcCtD
Naproxen—ALB—Folate Metabolism—DHFR—malaria	0.000165	0.00549	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000165	0.00549	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000165	0.00548	CbGpPWpGaD
Naproxen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000164	0.00544	CbGpPWpGaD
Naproxen—Dry mouth—Pentoxifylline—malaria	0.000163	0.000701	CcSEcCtD
Naproxen—ALB—Folate Metabolism—SCARB1—malaria	0.000163	0.00544	CbGpPWpGaD
Naproxen—Musculoskeletal discomfort—Quinidine—malaria	0.000162	0.000695	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Quinine—malaria	0.000162	0.000695	CcSEcCtD
Naproxen—Confusional state—Quinidine barbiturate—malaria	0.000162	0.000694	CcSEcCtD
Naproxen—Dyspnoea—Clindamycin—malaria	0.000162	0.000693	CcSEcCtD
Naproxen—Confusional state—Pentoxifylline—malaria	0.000162	0.000693	CcSEcCtD
Naproxen—Oedema—Quinidine barbiturate—malaria	0.000161	0.000689	CcSEcCtD
Naproxen—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.00016	0.00534	CbGpPWpGaD
Naproxen—Oedema—Pentoxifylline—malaria	0.00016	0.000687	CcSEcCtD
Naproxen—Anaphylactic shock—Pentoxifylline—malaria	0.00016	0.000687	CcSEcCtD
Naproxen—Dyspepsia—Clindamycin—malaria	0.00016	0.000685	CcSEcCtD
Naproxen—Infection—Pentoxifylline—malaria	0.000159	0.000683	CcSEcCtD
Naproxen—Dyspnoea—Quinidine—malaria	0.000159	0.00068	CcSEcCtD
Naproxen—Dyspnoea—Quinine—malaria	0.000159	0.00068	CcSEcCtD
Naproxen—Shock—Quinidine barbiturate—malaria	0.000158	0.000677	CcSEcCtD
Naproxen—UGT1A1—Biological oxidations—HPGDS—malaria	0.000158	0.00526	CbGpPWpGaD
Naproxen—Shock—Pentoxifylline—malaria	0.000158	0.000676	CcSEcCtD
Naproxen—Nervous system disorder—Quinidine barbiturate—malaria	0.000157	0.000675	CcSEcCtD
Naproxen—Thrombocytopenia—Quinidine barbiturate—malaria	0.000157	0.000674	CcSEcCtD
Naproxen—Thrombocytopenia—Pentoxifylline—malaria	0.000157	0.000673	CcSEcCtD
Naproxen—Tachycardia—Quinidine barbiturate—malaria	0.000157	0.000672	CcSEcCtD
Naproxen—Gastrointestinal disorder—Clindamycin—malaria	0.000157	0.000671	CcSEcCtD
Naproxen—Tachycardia—Pentoxifylline—malaria	0.000156	0.000671	CcSEcCtD
Naproxen—Fatigue—Clindamycin—malaria	0.000156	0.000671	CcSEcCtD
Naproxen—Skin disorder—Quinidine barbiturate—malaria	0.000156	0.000669	CcSEcCtD
Naproxen—Skin disorder—Pentoxifylline—malaria	0.000156	0.000668	CcSEcCtD
Naproxen—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000155	0.00517	CbGpPWpGaD
Naproxen—Hyperhidrosis—Quinidine barbiturate—malaria	0.000155	0.000666	CcSEcCtD
Naproxen—Pain—Clindamycin—malaria	0.000155	0.000665	CcSEcCtD
Naproxen—Constipation—Clindamycin—malaria	0.000155	0.000665	CcSEcCtD
Naproxen—Hyperhidrosis—Pentoxifylline—malaria	0.000155	0.000664	CcSEcCtD
Naproxen—Vomiting—Sulfadiazine—malaria	0.000155	0.000664	CcSEcCtD
Naproxen—Decreased appetite—Quinidine—malaria	0.000155	0.000663	CcSEcCtD
Naproxen—Decreased appetite—Quinine—malaria	0.000155	0.000663	CcSEcCtD
Naproxen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000154	0.00513	CbGpPWpGaD
Naproxen—Gastrointestinal disorder—Quinidine—malaria	0.000154	0.000659	CcSEcCtD
Naproxen—Gastrointestinal disorder—Quinine—malaria	0.000154	0.000659	CcSEcCtD
Naproxen—Rash—Sulfadiazine—malaria	0.000154	0.000658	CcSEcCtD
Naproxen—Dermatitis—Sulfadiazine—malaria	0.000153	0.000658	CcSEcCtD
Naproxen—Gastrointestinal pain—Dapsone—malaria	0.000153	0.000657	CcSEcCtD
Naproxen—Anorexia—Quinidine barbiturate—malaria	0.000153	0.000656	CcSEcCtD
Naproxen—Anorexia—Pentoxifylline—malaria	0.000153	0.000655	CcSEcCtD
Naproxen—Headache—Sulfadiazine—malaria	0.000153	0.000654	CcSEcCtD
Naproxen—Hypotension—Quinidine barbiturate—malaria	0.00015	0.000643	CcSEcCtD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—malaria	0.00015	0.00499	CbGpPWpGaD
Naproxen—Hypotension—Pentoxifylline—malaria	0.00015	0.000642	CcSEcCtD
Naproxen—Gastrointestinal pain—Clindamycin—malaria	0.000148	0.000636	CcSEcCtD
Naproxen—Body temperature increased—Dapsone—malaria	0.000148	0.000636	CcSEcCtD
Naproxen—Abdominal pain—Dapsone—malaria	0.000148	0.000636	CcSEcCtD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000147	0.00489	CbGpPWpGaD
Naproxen—Feeling abnormal—Quinine—malaria	0.000147	0.000629	CcSEcCtD
Naproxen—Feeling abnormal—Quinidine—malaria	0.000147	0.000629	CcSEcCtD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000146	0.00487	CbGpPWpGaD
Naproxen—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000146	0.000627	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000146	0.000626	CcSEcCtD
Naproxen—Gastrointestinal pain—Quinine—malaria	0.000145	0.000624	CcSEcCtD
Naproxen—Gastrointestinal pain—Quinidine—malaria	0.000145	0.000624	CcSEcCtD
Naproxen—Insomnia—Pentoxifylline—malaria	0.000145	0.000622	CcSEcCtD
Naproxen—Nausea—Sulfadiazine—malaria	0.000145	0.00062	CcSEcCtD
Naproxen—Urticaria—Clindamycin—malaria	0.000144	0.000618	CcSEcCtD
Naproxen—Abdominal pain—Clindamycin—malaria	0.000143	0.000615	CcSEcCtD
Naproxen—Body temperature increased—Clindamycin—malaria	0.000143	0.000615	CcSEcCtD
Naproxen—Dyspnoea—Quinidine barbiturate—malaria	0.000143	0.000614	CcSEcCtD
Naproxen—Dyspnoea—Pentoxifylline—malaria	0.000143	0.000613	CcSEcCtD
Naproxen—Somnolence—Quinidine barbiturate—malaria	0.000143	0.000612	CcSEcCtD
Naproxen—Somnolence—Pentoxifylline—malaria	0.000142	0.000611	CcSEcCtD
Naproxen—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000142	0.00474	CbGpPWpGaD
Naproxen—Urticaria—Quinidine—malaria	0.000141	0.000606	CcSEcCtD
Naproxen—Urticaria—Quinine—malaria	0.000141	0.000606	CcSEcCtD
Naproxen—Dyspepsia—Pentoxifylline—malaria	0.000141	0.000605	CcSEcCtD
Naproxen—Abdominal pain—Quinidine—malaria	0.000141	0.000603	CcSEcCtD
Naproxen—Abdominal pain—Quinine—malaria	0.000141	0.000603	CcSEcCtD
Naproxen—Body temperature increased—Quinidine—malaria	0.000141	0.000603	CcSEcCtD
Naproxen—Body temperature increased—Quinine—malaria	0.000141	0.000603	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.00014	0.00467	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.00014	0.00466	CbGpPWpGaD
Naproxen—Decreased appetite—Quinidine barbiturate—malaria	0.00014	0.000599	CcSEcCtD
Naproxen—Decreased appetite—Pentoxifylline—malaria	0.000139	0.000597	CcSEcCtD
Naproxen—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000139	0.000594	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000138	0.0046	CbGpPWpGaD
Naproxen—Constipation—Quinidine barbiturate—malaria	0.000137	0.000589	CcSEcCtD
Naproxen—Pain—Quinidine barbiturate—malaria	0.000137	0.000589	CcSEcCtD
Naproxen—Constipation—Pentoxifylline—malaria	0.000137	0.000588	CcSEcCtD
Naproxen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000137	0.00456	CbGpPWpGaD
Naproxen—Hypersensitivity—Clindamycin—malaria	0.000134	0.000573	CcSEcCtD
Naproxen—Feeling abnormal—Quinidine barbiturate—malaria	0.000132	0.000567	CcSEcCtD
Naproxen—Feeling abnormal—Pentoxifylline—malaria	0.000132	0.000566	CcSEcCtD
Naproxen—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000131	0.000563	CcSEcCtD
Naproxen—Hypersensitivity—Quinine—malaria	0.000131	0.000562	CcSEcCtD
Naproxen—Hypersensitivity—Quinidine—malaria	0.000131	0.000562	CcSEcCtD
Naproxen—Gastrointestinal pain—Pentoxifylline—malaria	0.000131	0.000562	CcSEcCtD
Naproxen—Asthenia—Clindamycin—malaria	0.00013	0.000558	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.00013	0.00432	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—HPGDS—malaria	0.000129	0.00428	CbGpPWpGaD
Naproxen—Pruritus—Clindamycin—malaria	0.000128	0.00055	CcSEcCtD
Naproxen—Asthenia—Quinine—malaria	0.000128	0.000547	CcSEcCtD
Naproxen—Asthenia—Quinidine—malaria	0.000128	0.000547	CcSEcCtD
Naproxen—Urticaria—Quinidine barbiturate—malaria	0.000128	0.000547	CcSEcCtD
Naproxen—Urticaria—Pentoxifylline—malaria	0.000127	0.000546	CcSEcCtD
Naproxen—Body temperature increased—Quinidine barbiturate—malaria	0.000127	0.000544	CcSEcCtD
Naproxen—Abdominal pain—Quinidine barbiturate—malaria	0.000127	0.000544	CcSEcCtD
Naproxen—Body temperature increased—Pentoxifylline—malaria	0.000127	0.000543	CcSEcCtD
Naproxen—Abdominal pain—Pentoxifylline—malaria	0.000127	0.000543	CcSEcCtD
Naproxen—Pruritus—Quinine—malaria	0.000126	0.00054	CcSEcCtD
Naproxen—Pruritus—Quinidine—malaria	0.000126	0.00054	CcSEcCtD
Naproxen—Diarrhoea—Clindamycin—malaria	0.000124	0.000532	CcSEcCtD
Naproxen—Diarrhoea—Quinidine—malaria	0.000122	0.000522	CcSEcCtD
Naproxen—Diarrhoea—Quinine—malaria	0.000122	0.000522	CcSEcCtD
Naproxen—Dizziness—Clindamycin—malaria	0.00012	0.000514	CcSEcCtD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.00012	0.00399	CbGpPWpGaD
Naproxen—Vomiting—Dapsone—malaria	0.000119	0.000511	CcSEcCtD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000119	0.00395	CbGpPWpGaD
Naproxen—Hypersensitivity—Quinidine barbiturate—malaria	0.000118	0.000507	CcSEcCtD
Naproxen—Hypersensitivity—Pentoxifylline—malaria	0.000118	0.000506	CcSEcCtD
Naproxen—Dizziness—Quinine—malaria	0.000118	0.000505	CcSEcCtD
Naproxen—Dizziness—Quinidine—malaria	0.000118	0.000505	CcSEcCtD
Naproxen—Headache—Dapsone—malaria	0.000117	0.000504	CcSEcCtD
Naproxen—AKR1C3—Metabolism—DHODH—malaria	0.000115	0.00384	CbGpPWpGaD
Naproxen—Vomiting—Clindamycin—malaria	0.000115	0.000494	CcSEcCtD
Naproxen—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000115	0.00384	CbGpPWpGaD
Naproxen—Asthenia—Quinidine barbiturate—malaria	0.000115	0.000494	CcSEcCtD
Naproxen—Asthenia—Pentoxifylline—malaria	0.000115	0.000493	CcSEcCtD
Naproxen—Rash—Clindamycin—malaria	0.000114	0.00049	CcSEcCtD
Naproxen—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.000114	0.0038	CbGpPWpGaD
Naproxen—Dermatitis—Clindamycin—malaria	0.000114	0.00049	CcSEcCtD
Naproxen—Headache—Clindamycin—malaria	0.000114	0.000487	CcSEcCtD
Naproxen—Pruritus—Quinidine barbiturate—malaria	0.000114	0.000487	CcSEcCtD
Naproxen—ALB—Vitamin B12 Metabolism—CRP—malaria	0.000114	0.00378	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000114	0.00378	CbGpPWpGaD
Naproxen—Pruritus—Pentoxifylline—malaria	0.000113	0.000486	CcSEcCtD
Naproxen—Vomiting—Quinine—malaria	0.000113	0.000485	CcSEcCtD
Naproxen—Vomiting—Quinidine—malaria	0.000113	0.000485	CcSEcCtD
Naproxen—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000113	0.00376	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—SLC4A1—malaria	0.000113	0.00375	CbGpPWpGaD
Naproxen—Rash—Quinidine—malaria	0.000112	0.000481	CcSEcCtD
Naproxen—Rash—Quinine—malaria	0.000112	0.000481	CcSEcCtD
Naproxen—Dermatitis—Quinidine—malaria	0.000112	0.000481	CcSEcCtD
Naproxen—Dermatitis—Quinine—malaria	0.000112	0.000481	CcSEcCtD
Naproxen—Headache—Quinidine—malaria	0.000111	0.000478	CcSEcCtD
Naproxen—Headache—Quinine—malaria	0.000111	0.000478	CcSEcCtD
Naproxen—Nausea—Dapsone—malaria	0.000111	0.000478	CcSEcCtD
Naproxen—Diarrhoea—Quinidine barbiturate—malaria	0.00011	0.000471	CcSEcCtD
Naproxen—Diarrhoea—Pentoxifylline—malaria	0.00011	0.00047	CcSEcCtD
Naproxen—Nausea—Clindamycin—malaria	0.000108	0.000462	CcSEcCtD
Naproxen—ALB—Folate Metabolism—IL4—malaria	0.000107	0.00356	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000107	0.00355	CbGpPWpGaD
Naproxen—Dizziness—Quinidine barbiturate—malaria	0.000106	0.000455	CcSEcCtD
Naproxen—Dizziness—Pentoxifylline—malaria	0.000106	0.000454	CcSEcCtD
Naproxen—Nausea—Quinidine—malaria	0.000106	0.000453	CcSEcCtD
Naproxen—Nausea—Quinine—malaria	0.000106	0.000453	CcSEcCtD
Naproxen—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000105	0.0035	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000104	0.00347	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000104	0.00347	CbGpPWpGaD
Naproxen—Vomiting—Quinidine barbiturate—malaria	0.000102	0.000438	CcSEcCtD
Naproxen—Vomiting—Pentoxifylline—malaria	0.000102	0.000437	CcSEcCtD
Naproxen—Rash—Quinidine barbiturate—malaria	0.000101	0.000434	CcSEcCtD
Naproxen—Dermatitis—Quinidine barbiturate—malaria	0.000101	0.000434	CcSEcCtD
Naproxen—Rash—Pentoxifylline—malaria	0.000101	0.000433	CcSEcCtD
Naproxen—Dermatitis—Pentoxifylline—malaria	0.000101	0.000433	CcSEcCtD
Naproxen—Headache—Quinidine barbiturate—malaria	0.000101	0.000431	CcSEcCtD
Naproxen—Headache—Pentoxifylline—malaria	0.0001	0.000431	CcSEcCtD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	9.97e-05	0.00332	CbGpPWpGaD
Naproxen—CYP1A2—Phase II conjugation—HPGDS—malaria	9.88e-05	0.00329	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—SLC4A1—malaria	9.82e-05	0.00327	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	9.57e-05	0.00319	CbGpPWpGaD
Naproxen—Nausea—Quinidine barbiturate—malaria	9.54e-05	0.000409	CcSEcCtD
Naproxen—Nausea—Pentoxifylline—malaria	9.52e-05	0.000408	CcSEcCtD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	9.4e-05	0.00313	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—CRP—malaria	9.24e-05	0.00308	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—DECR1—malaria	9.23e-05	0.00307	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—CRP—malaria	9.07e-05	0.00302	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	9.02e-05	0.003	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PKLR—malaria	8.88e-05	0.00296	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	8.86e-05	0.00295	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—CD36—malaria	8.79e-05	0.00293	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—ICAM1—malaria	8.49e-05	0.00283	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	8.37e-05	0.00279	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—HBB—malaria	8.35e-05	0.00278	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	8.34e-05	0.00278	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—HPGDS—malaria	8.31e-05	0.00277	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL4—malaria	8.3e-05	0.00276	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IFNG—malaria	7.99e-05	0.00266	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IFNG—malaria	7.94e-05	0.00264	CbGpPWpGaD
Naproxen—AKR1C3—Disease—G6PD—malaria	7.92e-05	0.00264	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—DHODH—malaria	7.59e-05	0.00253	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PKLR—malaria	7.44e-05	0.00248	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—CRP—malaria	7.34e-05	0.00244	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	7.16e-05	0.00238	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL1B—malaria	7.13e-05	0.00237	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL1B—malaria	7.08e-05	0.00236	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	6.9e-05	0.0023	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TLR4—malaria	6.88e-05	0.00229	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—HPGDS—malaria	6.77e-05	0.00225	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—ICAM1—malaria	6.75e-05	0.00225	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—G6PD—malaria	6.63e-05	0.00221	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—DHODH—malaria	6.61e-05	0.0022	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—ICAM1—malaria	6.59e-05	0.0022	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ACKR1—malaria	6.56e-05	0.00218	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—CD36—malaria	6.54e-05	0.00218	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—NOS2—malaria	6.54e-05	0.00218	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.5e-05	0.00216	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IFNG—malaria	6.46e-05	0.00215	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	6.45e-05	0.00215	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—SLC4A1—malaria	6.45e-05	0.00215	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CD4—malaria	6.36e-05	0.00212	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IFNG—malaria	6.34e-05	0.00211	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—DHODH—malaria	6.16e-05	0.00205	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—DECR1—malaria	6.06e-05	0.00202	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	6.03e-05	0.00201	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.96e-05	0.00199	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	5.86e-05	0.00195	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	5.83e-05	0.00194	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	5.79e-05	0.00193	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—HPGDS—malaria	5.78e-05	0.00192	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL1B—malaria	5.76e-05	0.00192	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HBB—malaria	5.75e-05	0.00192	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL2—malaria	5.74e-05	0.00191	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL1B—malaria	5.66e-05	0.00188	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—SLC4A1—malaria	5.62e-05	0.00187	CbGpPWpGaD
Naproxen—AKR1C3—Disease—DHFR—malaria	5.6e-05	0.00186	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—HBB—malaria	5.48e-05	0.00183	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	5.38e-05	0.00179	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	5.36e-05	0.00178	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TLR9—malaria	5.29e-05	0.00176	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—DECR1—malaria	5.28e-05	0.00176	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—SLC4A1—malaria	5.24e-05	0.00174	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	5.2e-05	0.00173	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—malaria	5.17e-05	0.00172	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—malaria	5.14e-05	0.00171	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—malaria	5.13e-05	0.00171	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—HPGDS—malaria	5.06e-05	0.00168	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DHODH—malaria	5.02e-05	0.00167	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—malaria	5.02e-05	0.00167	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.94e-05	0.00165	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—DECR1—malaria	4.93e-05	0.00164	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PKLR—malaria	4.89e-05	0.00163	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—HBB—malaria	4.78e-05	0.00159	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	4.74e-05	0.00158	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—DHFR—malaria	4.69e-05	0.00156	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—SCARB1—malaria	4.64e-05	0.00155	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL1B—malaria	4.58e-05	0.00152	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.54e-05	0.00151	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL1B—malaria	4.48e-05	0.00149	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL2—malaria	4.46e-05	0.00148	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—HBB—malaria	4.46e-05	0.00148	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—G6PD—malaria	4.36e-05	0.00145	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SLC4A1—malaria	4.27e-05	0.00142	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PKLR—malaria	4.26e-05	0.00142	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—malaria	4.18e-05	0.00139	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—malaria	4.17e-05	0.00139	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—malaria	4.15e-05	0.00138	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—malaria	4.11e-05	0.00137	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	4.05e-05	0.00135	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DECR1—malaria	4.02e-05	0.00134	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DHODH—malaria	3.99e-05	0.00133	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PKLR—malaria	3.97e-05	0.00132	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.92e-05	0.00131	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	3.9e-05	0.0013	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	3.9e-05	0.0013	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—CD36—malaria	3.9e-05	0.0013	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—G6PD—malaria	3.79e-05	0.00126	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—malaria	3.74e-05	0.00125	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HBB—malaria	3.63e-05	0.00121	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.6e-05	0.0012	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—G6PD—malaria	3.54e-05	0.00118	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SLC4A1—malaria	3.39e-05	0.00113	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—malaria	3.37e-05	0.00112	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—HPGDS—malaria	3.32e-05	0.00111	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—malaria	3.32e-05	0.00111	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—malaria	3.31e-05	0.0011	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—malaria	3.25e-05	0.00108	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DHODH—malaria	3.25e-05	0.00108	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PKLR—malaria	3.24e-05	0.00108	CbGpPWpGaD
Naproxen—ALB—Metabolism—DHODH—malaria	3.23e-05	0.00107	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.19e-05	0.00106	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DECR1—malaria	3.19e-05	0.00106	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.17e-05	0.00106	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—DHFR—malaria	3.08e-05	0.00103	CbGpPWpGaD
Naproxen—PTGS2—Disease—PKLR—malaria	3.07e-05	0.00102	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—SCARB1—malaria	3.05e-05	0.00102	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.93e-05	0.000976	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.91e-05	0.00097	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CD36—malaria	2.91e-05	0.00097	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—HPGDS—malaria	2.89e-05	0.000963	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—G6PD—malaria	2.89e-05	0.000961	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HBB—malaria	2.88e-05	0.00096	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS2—malaria	2.86e-05	0.000952	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.85e-05	0.000948	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC4A1—malaria	2.76e-05	0.000919	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC4A1—malaria	2.74e-05	0.000914	CbGpPWpGaD
Naproxen—PTGS2—Disease—G6PD—malaria	2.74e-05	0.000911	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—HPGDS—malaria	2.7e-05	0.000899	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—DHFR—malaria	2.68e-05	0.000894	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—malaria	2.68e-05	0.000893	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—SCARB1—malaria	2.66e-05	0.000884	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DHODH—malaria	2.64e-05	0.000879	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—malaria	2.62e-05	0.000872	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.6e-05	0.000865	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DECR1—malaria	2.59e-05	0.000864	CbGpPWpGaD
Naproxen—ALB—Metabolism—DECR1—malaria	2.58e-05	0.000859	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PKLR—malaria	2.57e-05	0.000856	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—DHFR—malaria	2.5e-05	0.000834	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—SCARB1—malaria	2.48e-05	0.000825	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.39e-05	0.000794	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HBB—malaria	2.35e-05	0.000781	CbGpPWpGaD
Naproxen—ALB—Metabolism—HBB—malaria	2.33e-05	0.000777	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—G6PD—malaria	2.29e-05	0.000763	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	2.26e-05	0.000753	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DHODH—malaria	2.26e-05	0.000751	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC4A1—malaria	2.25e-05	0.000748	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.22e-05	0.000739	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.21e-05	0.000735	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HPGDS—malaria	2.2e-05	0.000733	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2—malaria	2.18e-05	0.000727	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD4—malaria	2.12e-05	0.000705	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DECR1—malaria	2.11e-05	0.000703	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—KDR—malaria	2.11e-05	0.000701	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PKLR—malaria	2.09e-05	0.000696	CbGpPWpGaD
Naproxen—ALB—Metabolism—PKLR—malaria	2.08e-05	0.000692	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DHFR—malaria	2.04e-05	0.00068	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.04e-05	0.000679	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SCARB1—malaria	2.02e-05	0.000673	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CD36—malaria	2.01e-05	0.000669	CbGpPWpGaD
Naproxen—PTGS2—Disease—DHFR—malaria	1.94e-05	0.000644	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC4A1—malaria	1.92e-05	0.000639	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CD36—malaria	1.91e-05	0.000637	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HBB—malaria	1.91e-05	0.000636	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—G6PD—malaria	1.86e-05	0.000621	CbGpPWpGaD
Naproxen—ALB—Metabolism—G6PD—malaria	1.85e-05	0.000617	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.84e-05	0.000612	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.83e-05	0.000609	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DECR1—malaria	1.8e-05	0.000601	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HPGDS—malaria	1.75e-05	0.000582	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PKLR—malaria	1.7e-05	0.000567	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CD36—malaria	1.67e-05	0.000555	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—malaria	1.65e-05	0.00055	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HBB—malaria	1.63e-05	0.000543	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DHFR—malaria	1.62e-05	0.00054	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SCARB1—malaria	1.6e-05	0.000534	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CD36—malaria	1.56e-05	0.000518	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—G6PD—malaria	1.52e-05	0.000505	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.5e-05	0.000498	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PKLR—malaria	1.45e-05	0.000484	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HPGDS—malaria	1.42e-05	0.000473	CbGpPWpGaD
Naproxen—ALB—Metabolism—HPGDS—malaria	1.41e-05	0.000471	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—malaria	1.36e-05	0.000454	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DHFR—malaria	1.32e-05	0.000439	CbGpPWpGaD
Naproxen—ALB—Metabolism—DHFR—malaria	1.31e-05	0.000437	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SCARB1—malaria	1.31e-05	0.000435	CbGpPWpGaD
Naproxen—ALB—Metabolism—SCARB1—malaria	1.3e-05	0.000432	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—G6PD—malaria	1.3e-05	0.000432	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.28e-05	0.000426	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CD36—malaria	1.27e-05	0.000422	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HPGDS—malaria	1.16e-05	0.000385	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—malaria	1.15e-05	0.000381	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—malaria	1.13e-05	0.000375	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DHFR—malaria	1.07e-05	0.000357	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SCARB1—malaria	1.06e-05	0.000354	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD36—malaria	1.01e-05	0.000335	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HPGDS—malaria	9.89e-06	0.000329	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—malaria	9.88e-06	0.000329	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DHFR—malaria	9.17e-06	0.000305	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SCARB1—malaria	9.08e-06	0.000302	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD36—malaria	8.19e-06	0.000273	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD36—malaria	8.14e-06	0.000271	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—malaria	8.02e-06	0.000267	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD4—malaria	7.32e-06	0.000244	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD36—malaria	6.67e-06	0.000222	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD36—malaria	5.7e-06	0.00019	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—malaria	3.96e-06	0.000132	CbGpPWpGaD
